Skip to main content
Top
Published in: Archives of Virology 3/2016

01-03-2016 | Erratum

Erratum to: Immunogenicity and antigenic relationships among spike proteins of porcine epidemic diarrhea virus subtypes G1 and G2

Authors: Xiaobo Wang, Jianfei Chen, Da Shi, Hongyan Shi, Xin Zhang, Jing Yuan, Shibo Jiang, Li Feng

Published in: Archives of Virology | Issue 3/2016

Login to get access

Excerpt

In the original publication, Table 2 was overlooked by the author during proof checking. The correct version of Table 2 is given below:
Table 2
The luminescence intensity of fluorescence of anti-S polyclonal antibodies against different types of virus
 
Dilution of anti-CV777 S polyclonal antisera
1600
3200
6400
12800
25600
51200
102400
CV777
+++
+++
++
++
+
+
-
LNCT2
+++
+++
++
++
+
-
-
Vero E6
-
-
-
-
-
-
-
 
Dilution of anti-LNCT2 S polyclonal antisera
1600
3200
6400
12800
25600
51200
102400
LNCT2
+++
+++
++
++
+
+
-
CV777
+++
+++
++
++
+
-
-
Vero E6
-
-
-
-
-
-
-
The luminescence intensity was divided into four degrees: (+++) strong, (++) moderate, (+) weak and (-) negative
Metadata
Title
Erratum to: Immunogenicity and antigenic relationships among spike proteins of porcine epidemic diarrhea virus subtypes G1 and G2
Authors
Xiaobo Wang
Jianfei Chen
Da Shi
Hongyan Shi
Xin Zhang
Jing Yuan
Shibo Jiang
Li Feng
Publication date
01-03-2016
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 3/2016
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-016-2766-2

Other articles of this Issue 3/2016

Archives of Virology 3/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine